Activation of maternal behavior of albino rats after combined treatment with dopamine and opioid receptor antagonists in low doses

Bulletin of Experimental Biology and Medicine

Volumn 142, Issue 2, 2006, Pages 161-164

  Dobryakova, Yu V ^a   Belyaeva, Yu A ^a   Stovolosov, I S ^a   Dubynin, V A ^a   Kamenskii, A A ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Dopaminergic system; Haloperidol; Maternal behavior; Naloxone; Opioid system

Indexed keywords

DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; NALOXONE; OPIATE ANTAGONIST;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; EXPLORATORY BEHAVIOR; FEMALE; LOW DRUG DOSE; MATERNAL BEHAVIOR; MOTIVATION; MOTOR ACTIVITY; NEWBORN; NONHUMAN; RAT; RAT STRAIN;

ANALYSIS OF VARIANCE; ANIMALS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; FEMALE; HALOPERIDOL; MATERNAL BEHAVIOR; MOTOR ACTIVITY; NALOXONE; RATS; RECEPTORS, OPIOID;

EID: 33751220185     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-006-0316-8     Document Type: Article

References (13)

1. L. V. Devoino and R. Yu. Il'yuchenok, Neuromediator Systems in Psycho-Neuroimmunomodulation: Dopamine, Serotonin, GABA, Neuropeptides [in Russian], Novosibirsk (1993).
2. Yu. V. Dobryakova, V. A. Dubynin, Yu. A. Ivleva, et al., Byull. Eksp. Biol. Med., 137, No. 7, 14-17 (2005).
3. V. A. Dubynin, Yu. V. Dobryakova, Yu. A. Belyaeva, et al., Fiziol. Zh., 95, No. 1, 80-88 (2005).
4. V. A. Dubynin, A. S. Maklakova, L. A. Andreeva, et al., Vestn. Moskovsk. Gos. Universiteta, series Biology, No. 1, 3-9 (1999).
5. E. M. Byrnes, B. A. Rigero, and R. S. Bridges, Pharmacol. Biochem. Behav., 73, No. 4, 869-875 (2002).
6. C. L. Dennis, BMJ, 331, No. 7507, 15-18 (2005).
7. J. F. Leckman and A. E. Herman, Biol. Psychiatry, 51, No. 1, 27-43 (2002).
8. J. S. Lonstein, J. M. Dominguez, S. K. Putnam, et al., Brain Res., 970, Nos. 1-2, 149-158 (2003).
9. M. R. Silva, M. M. Bernardi, P. E. Cruz-Casallas, and L. F. Felicio, Pharmacol. Toxicol., 93, No. 1, 42-47 (2003).
10. M. R. Silva, M. M. Bernardi, and L. F. Felicio, Pharmacol. Biochem. Behav., 68, No. 3, 461-468 (2001).
11. S. G. Speciale, K. F. Manaye, M. Sadeq, and D. C. German, J. Neural Transm. Gen. Sect., 91, No. 1, 53-66 (1993).
12. J. M. Stern and S. E. Keer, Behav. Brain Res., 99, No. 2, 231-239 (1999).
13. J. M. Stern and M. Protomastro, Pharmacol. Biochem. Behav., 66, No. 2, 353-359 (2002).